Integrative Network Pharmacology and Molecular Docking Approaches in Herbal Medicine Research. A Systematic Review of Applications, Advances, and Translational Potential
Authors:
- Swase Dominic TerkimbiSTSwase Dominic Terkimbi
- Regan MujinyaRMRegan Mujinya
- Keith L KayanjaKKKeith L Kayanja
- Bot Yakubu SundayBSBot Yakubu Sunday
- Reuben Samson DanganaRDReuben Samson Dangana
- Ugwu Okechukwu Paul-ChimaUgwu Okechukwu Paul-Chima
- Patrick Maduabuchi AjaPAPatrick Maduabuchi Aja
- Joseph KibirigeJKJoseph Kibirige
Open Access
- 9 December 2025
- journal article
- review article
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 1384
Abstract
Background Network pharmacology and molecular docking have emerged as important in modern herbal drug discovery, offering systems-level understanding into phytochemical interactions and therapeutic mechanisms. This review aimed to evaluate the application of integrated network pharmacology and molecular docking in herbal medicine research Methods A systematic search was conducted across PubMed, Scopus, and Web of Science for studies published between 2010 and August, 2025. Eligible studies included both network pharmacology and molecular docking in medicinal plants, botanical formulations, or isolated phytochemicals. Screening and selection followed PRISMA-ScR guidelines. Data were extracted on study characteristics, computational platforms, biological validation strategies, phytochemical profiles, protein targets, and mechanistic pathways. Results 36 studies met the eligibility criteria. Publications increased significantly after 2020, with most originating from Asia, particularly China (55.6%) and India (25.0%). Majority (61.1%) employed purely in silico pipelines, while 22.2% combined computational and in vitro validation, and 16.7% incorporated in vivo models. Flavonoids such as quercetin, kaempferol, apigenin, and luteolin accounted for most docked phytochemicals. Key molecular targets included ESR1, EGFR, AKT1, TNF, CASP3, and PTGS2, aligning predominantly with cancer, inflammatory, and metabolic pathways. Key signaling cascades PI3K-Akt, MAPK/ERK, NF-κB, and Wnt/β-catenin were consistently reported. Almost half of the studies (47.2%) integrated molecular dynamics simulations, while ADMET screening was reported in 71.4% of cases. Conclusion This review demonstrates that integrated network pharmacology and molecular docking have become foundational in herbal medicine research and growing with advances in computational biology. These approaches reveal multi-target mechanisms supporting the therapeutic potential of phytochemicals, yet translational progress is constrained by inconsistent pipelines. Strengthening validation frameworks, broadening phytochemical discovery beyond common flavonoids, and enhancing global research participation will be essential to accelerate clinically relevant herbal drug development.Keywords
This publication has 53 references indexed in Scilit:
- Artificial intelligence in drug discovery and development: transforming challenges into opportunitiesDiscover Pharmaceutical Sciences, 2025
- Deciphering the molecular mechanisms of Dashamoola in inflammatory bowel disease: A systems biology approach integrating network pharmacology, molecular simulations, and DFT analysisFood Bioscience, 2025
- Flavonoids and their role in oxidative stress, inflammation, and human diseasesChemico-Biological Interactions, 2025
- Targeting cell cycle arrest in breast cancer by phytochemicals from Caryto urens L. fruit ethyl acetate fraction: in silico and in vitro validationJournal of Ayurveda and Integrative Medicine, 2025
- Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and agingArchives of Toxicology, 2023
- Probing the mechanism of action (MOA) of Solanum nigrum Linn against breast cancer using network pharmacology and molecular dockingSN Applied Sciences, 2023
- Network pharmacology in quality control of traditional Chinese medicinesChinese Herbal Medicines, 2022
- Evaluation of tea (Camellia sinensis L.) phytochemicals as multi-disease modulators, a multidimensional in silico strategy with the combinations of network pharmacology, pharmacophore analysis, statistics and molecular dockingMolecular Diversity, 2022
- Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysisMolecular Diversity, 2021
- Pharmacological evaluation and in-silico modeling study of compounds isolated from Ziziphus oxyphyllaHeliyon, 2021